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Herbal and plant based remedies have been used since times immemorial for treating illnesses or maladies of variant aetiology, 
whereas during the past two centuries, the pharmaceutical chemists have discovered many important modern drugs from natural 
botanicals and microbes. Generally, herbal and plant-derived products containing multiple compounds are administered orally 
for therapeutic purposes. Currently, targeted drug-delivery systems are being developed and investigated for the treatment of 
membranes and devices are available for sustained release and to deliver steady supply of natural bioactive ingredients, herbal-
based extracts, and a few have been approved by US-FDA and other drug regulatory agencies. The purpose of this mini review 
plant and herbal origin as well as to underscore the potential for the delivery of cost-effective herbal ingredients and natural 
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INTRODUCTION
Herbal and natural botanicals have been used for treating 
human and animals diseases since ancient time in India, 
China, Egypt, Europe, Latin-America and Africa. Several 
investigations in experimental animals and a limited number 
of clinical observations have revealed that oral administration 
of herbal and plant products produce favorable results for the 
treatment of non-communicable diseases such as myocardial 
infarction and stroke, high blood pressure, type 2 diabetes, 
unknown origin, osteoarthritis, cancer, and postmenopausal 
symptoms (see Hassanzadeh et al, this volume of BMR). 
Also, herbal based medicines have been used for  wound and 
burn care from ancient times to date. For example, curcumin, 
the therapeutically active component of turmeric shows anti-
and hastens the healing process and reduces the risk of scar 
formation (1).   
In many cases, however, the underlying mechanisms 
and validation of biologically active ingredients of plant-
derived products remain unknown. There is an urgent need 
of well designed, double-blind, multicentre, clinical trials 
with adequate number of patients to determine the safety 
and effectiveness of plant-derived remedies as is done with 
synthetic pharmaceuticals. Such studies must contain a valid 
comparator to evaluate the therapeutic potential of herbal and 
plant products. Mostly, the plant- and food-derived compounds 
are well-tolerated by the human body, and therefore, their 
application for the development of alternative therapies may 
reduce high costs and duration of toxicological studies in 
drug discovery research, development of new substances, and 
clinical trials. The plant-based alternative therapies will be 
highly useful for patients who cannot afford long-term cure 
with costly synthetic medicines. 
THERAPEUTIC POTENTIAL OF HERBALS AND NATURAL 
BOTANICALS 
The most important data concerning the therapeutic potential 
of active ingredients of herbals and natural botanicals for 
the treatment of human diseases has originated from Asian 
countries, especially India and China. Indian Materia Medica 
includes about 2,000 medications of natural origin almost all 
of which are derived from different traditional systems and 
folklore practices (2). Ayurveda, which literally means the 
science of life, is one of the oldest system of medicines used 
in India. More than 25,000 single or poly-herbal formulations 
are used by the tribal and rural populations in India. But only 
6% of all therapeutically important species, which are noted 
in ancient literature, have been analyzed phytochemically 
for their therapeutic potential (3). Many important modern 
drugs have been discovered from natural botanicals and their 
pharmaceutical industry. The development of pharmaceutical 
chemistry and chemical analyses occurred in the early 19th 
century onward, and consequently led to the extraction, 
plant-derived extracts and/or ingredients into the synthesis 
of modern drugs (4, 5). Today, herbal medicines in their 
novel formulations such as nanoparticles, microemulsions, 
matrix systems, solid dispersions, liposomes, and solid lipid 
nanoparticles (SLNs), nanomicellar system, nanotubes, and 
colloidal nanogels have been developed to be used either alone 
or in combination with other chemotherapeutic agents (4, 6, 
7). The current focus of pharmaceutical researchers is towards 
design, characterization and development of targeted-drug 
delivery systems for synthetic drugs, herbal remedies, and 
as well as to deliver required quantity of a medicament to 
targeted diseased area (8-14). 
THE DELIVERY OF SYNTHETIC AND PLANT-DERIVED 
MEDICINES
The challenges for the systemic delivery of synthetic 
medicines, herbals and plant-derived products are dissolution 
and protection of bioactive constitutes in the highly acidic pH 
environment of the stomach, absorption of therapeutically 
active ingredients from the gastrointestinal tract, reduced 
biotransformation in the gut and liver, and ultimate delivery 
of the optimum quantity of bioactive substances to reach 
the circulating blood (4, 15). Due to their small size and 
increased surface area, nano-carriers are being promoted for 
the delivery of synthetic drugs and herbal remedies to maintain 
therapeutically required amount of drugs and  plant medicines 
to targeted diseased area as well as to overcome all the obstacles 
experienced for delivering the optimum quantity at the target 
site. Sharma et al. have reported (4) several advantages for the 
delivery of herbal remedies through nano-systems such as: (i) 
reduction in bulk doses, (ii) delivery at the targeted diseased 
area for major life threatening diseases, (iii) ease and comfort 
to patients over the traditional available formulations such as 
large doses but lesser effectiveness, (iv) ability to deliver high 
concentrations of drugs to diseased sites due to their unique 
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size and high loading capacities and persistence at the sites 
for the longer periods, (v) enhanced permeation and retention 
effect, (vi) reduced side effects, and (vii) reduction in the 
delivery-devices, the US-FDA and other drug regulatory bodies 
devices for the delivery of synthetic drugs and active herbal 
ingredients. There is a growing demand for further research 
to exploit the advantages offered by nanotechnology devices 
potentials for drug incorporation and drug release. Hence, the 
primary focus of this review is to highlight the biomedical 
cost-effective herbals and plant-derived therapies. The authors 
have evaluated the most important studies concerning the 
targeted-delivery of therapeutically active ingredients of plants 
and herbal remedies.
TARGETED DRUG-DELIVERY SYSTEMS 
Over the past two decades, interest for the biomedical 
applications of nanomaterials and nanotechnology devices 
have been growing for the targeted-delivery of synthetic 
and herbal medicines. The ultrasmall size molecules of 
nanotechnology materials, in the range of 1-100 nanometers, 
have unique physiochemical properties and interactions with 
biological systems, and these characteristics of nanodevices 
help in exploring the controlled delivery and steady supply of 
therapeutically active substances to targeted sites (16).  For 
the loading of biologically active materials in nano-fabricated 
devices, a variety of methods are used to incorporate synthetic 
drugs and plant-derived products with nanoparticles and 
chemical conjugation. The main advantages of nanoparticle-
based drug delivery system are: improvement of plasma or 
serum solubility of xenobiotics; prolongation of systemic 
circulation half-life; releasing the bioactive substance at a 
sustained and controlled manner; and preferentially delivering 
therapy to the targeted tissues and cells. A number of 
investigators have reported the usefulness of nanotechnology 
methods for the concurrent delivery of multiple therapeutic 
agents to the targeted tissues and cells (17, 18). With nanotech 
conventional drug delivery system, since the drug-loaded 
nanoparticles can enter host cells and invading microbial 
organisms easily as well as through endocytosis drug-payloads 
can be released to treat microbe-induced infections. 
       It is recognized that the plant-derived medicines are well 
tolerated by the human body and they produce lesser side 
effects compared to synthetic pharmaceuticals. Further, the 
herbals and plant-derived remedies are less costly for short- 
and long-term cure in comparison with synthetic drugs. Due 
and plant-derived medicines are gaining popularity worldwide, 
especially in developing countries. The delivery systems 
for natural botanicals can be fabricated using biomaterials, 
namely synthetic biocompatible and biodegradable polymers, 
microlipids, and polysaccharides (19). Such drug delivery 
methods would help to increase the therapeutic value of herbal 
remedies for the treatment of chronic diseases like asthma, 
diabetes mellitus, obesity, cancer, and other life threatening 
cardiovascular diseases. Examples of delivery systems of 
herbal medicines, and their biomedical applications are shown 
in Table 1.
POLYMERIC NANOFIBROUS-WOVEN DRUG DELIVERY 
SYSTEMS
been successfully fabricated (32), which offer high porosity 
with large surface area-to-volume ratio and are more suitable 
and waste excretion (33). Recently, the herbal and plant 
extracts, powder and nanoparticles intended for biomedical 
applications have been catching the attention of pharmaceutical 
researchers. Such therapeutic products are blended with 
Different herbal and plant products are incorporated in 
biocompatibility, biodegradability, and substance permeability 
for wound healing dressings as well as targeted-delivery of 
medicines and skin tissue engineering. The studies reported 
in the literature (34-38) are summarized in Table 2. 
CONCLUSION
This review summarizes the most recent developments 
and polymeric herbals and plant products incorporated for 
targeted-delivery of plant-derived remedies. These nano- and 
macro-structure promote their candidatures for biomedical 
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Table 1. Herbal and plant products delivery systems
 Delivery system Procedure Herbal and plant-derived products Biomedical applications Ref. 
Mouth dissolving 
tablets
Poly-herbal Eective for lung problems and other 
respiratory ailments like asthma , cardiac 
distress
(20)




 Granulated herb and a carrier Active ingredients from plants  consisting 
hypericin, hyperforin and chinacosides
Steady supply and sustained release of active 
components  for targeted drug delivery to cure 
diseases
(21)
Microgranules Extrusion-spheronization, uid 
air bed process or a coating-
pan method





Muco-adhesive polymers Echinacea, Lavender and Mastic gum Sustained release for the treatment of diseases (23)
Transdermal lms Transdermal drug- delivery 
system (TDDS)
Boswellic acid (Boswellia serrata) and 
curcumin (Curcuma longa)
For continuous administration of medicine 
through skin into the systemic circulation 
and to circumvent the rst-pass metabolism 
of the bioactive material, and to avoid pain 
associated with injection. Oers drug delivery 
with infrequent dosing via zero-order kinetics, 






within the buccal 
cavity of a human
Consisting of gels, pastes and 
chewing gums.
Radix Polygoni Multiori, Rhizoma 
drynariae, Rhizoma ligustici Chuanxiong, 
Calculus bovis, Indigo naturalis, Herba 
ecliptae, Pericarpium trichosanthis, Radix 
sophorae Flavescentis, Spina gleditsiae, 
Radix Angelicae sinensis, Fructus mori 
and Halitum. 






indicum, Flos Lonicera, Herba 
houttuynia, Radix Bupleurum 
and menthene
Flos Lonicera, Fructus forsythia and Radix 
scutellaria. 
Anti-inammatory and antiviral eects, a 
good curative eect in treating infantile upper 
respiratory tract infections.
(27)
Microparticles Formulated by dierent 
techniques using chitosan, 
egg albumin, sodium alginate, 
ethyl cellulose, cellulose 
acetate, gelatin and beeswax.
Gugulipid extract from the Oleo gum 
resin of Commiphora wightii 
To reduce the levels of harmful serum lipids in 
the blood stream.
(28)
Microcapsules  Layer-by-layer adsorption 
of carrageenan and 
oligochitosan onto calcium 
carbonate microparticles with 
their subsequent dissolving 
after the treatment of EDTA.
Plantain Plantago major and calendula 
Calendula ocinalis L. (PCE)




Drying, mincing, extracting, 
crushing into liquid particles 
with ultrasonic wave, ltering 
and nanometerizing into 
nanoparticles soliquid with 
nanometer collider.
Peach seed, saower, angelica root, 
Szechwan lovage rhizome, Rehmannia 
root, red peony root, leech, gady, earth 
worm and ground beetle, 





Chitosan  danshen (Radix Salvia miltiorrhiza), To  promote anastomosing and healing on 
muscles and tissues at the organic incision site 
in abdominal cavities.
(31)
ArthriBlend-SR Formulation containing herbal 
extracts and nutrients 
Glucosamine sulfate, Boswellin (Boswellia 
serrata extract) and Curcumin C3 
Complex (Curcuminoids from Curcuma 
longa) 
To support healthy joints and connective 
tissues in the body; natural actives for joint care 
applications; to support the management of 
inammatory conditions such as arthritis and the 
continuous management of symptoms of arthritis
(32)
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applications  in treating chronic diseases, including wound, 
and to reduce cure-cost and improve the quality of life of 
patients. Further work is needed to improve the fabrication 
Future studies should be done with different biocompatible 
herbal and plant extracts or their active ingredients to explore 
multidisciplinary approach and interdisciplinary research.
interest.
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